rs121908918
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001365536.1(SCN9A):c.1921A>T(p.Asn641Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,613,946 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001365536.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN9A | NM_001365536.1 | c.1921A>T | p.Asn641Tyr | missense_variant | 12/27 | ENST00000642356.2 | NP_001352465.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN9A | ENST00000642356.2 | c.1921A>T | p.Asn641Tyr | missense_variant | 12/27 | NM_001365536.1 | ENSP00000495601.1 | |||
SCN9A | ENST00000303354.11 | c.1921A>T | p.Asn641Tyr | missense_variant | 12/27 | 5 | ENSP00000304748.7 | |||
SCN9A | ENST00000409672.5 | c.1921A>T | p.Asn641Tyr | missense_variant | 12/27 | 5 | ENSP00000386306.1 | |||
SCN9A | ENST00000645907.1 | c.1921A>T | p.Asn641Tyr | missense_variant | 12/27 | ENSP00000495983.1 | ||||
SCN9A | ENST00000454569.6 | c.1921A>T | p.Asn641Tyr | missense_variant | 12/15 | 1 | ENSP00000413212.2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152142Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000242 AC: 6AN: 248300Hom.: 0 AF XY: 0.0000297 AC XY: 4AN XY: 134754
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1461804Hom.: 0 Cov.: 32 AF XY: 0.0000275 AC XY: 20AN XY: 727202
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152142Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74322
ClinVar
Submissions by phenotype
Generalized epilepsy with febrile seizures plus, type 7 Uncertain:1Benign:1
Benign, criteria provided, single submitter | case-control | New Leaf Center | Jul 10, 2020 | We identify the p.(Asn641Tyr) in heterozygous state in 18 Amish individuals without history of generalised febrile or afebrile seizures (one individual has focal seizures), inconstant with it as a cause of a monogenic epilepsy disorder. This variant had been previously described by Singh et al 2009. - |
Uncertain significance, no assertion criteria provided | literature only | OMIM | Sep 01, 2009 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 08, 2022 | The p.N641Y variant (also known as c.1921A>T), located in coding exon 11 of the SCN9A gene, results from an A to T substitution at nucleotide position 1921. The asparagine at codon 641 is replaced by tyrosine, an amino acid with dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 21, 2023 | This sequence change replaces asparagine, which is neutral and polar, with tyrosine, which is neutral and polar, at codon 641 of the SCN9A protein (p.Asn641Tyr). This variant is present in population databases (rs121908918, gnomAD 0.006%). This missense change has been observed in individual(s) with febrile seizures and seizures (PMID: 19763161, 33216760). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 6366). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SCN9A protein function with a negative predictive value of 95%. Experimental studies have shown that this missense change affects SCN9A function (PMID: 19763161, 31372899). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Primary erythromelalgia;C1833661:Paroxysmal extreme pain disorder;C1855739:Channelopathy-associated congenital insensitivity to pain, autosomal recessive;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Other:1
not provided, no classification provided | phenotyping only | GenomeConnect - Invitae Patient Insights Network | - | Variant interpreted as Pathogenic and reported on 01-22-2020 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at